- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 116,230 | 22.08.24 20:28:10 | +0,200 | +0,17% | 116,220 | 116,240 | 114,780 | 116,030 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 103,630 | 22.08.24 20:25:40 | -2,450 | -2,31% | 103,280 | 104,010 | 105,000 | 106,080 |
